Literature DB >> 30628563

Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut-liver axis.

N M Delzenne1, C Knudsen1, M Beaumont1, J Rodriguez1, A M Neyrinck1, L B Bindels1.   

Abstract

This review presents mechanistic studies performed in vitro and in animal models, as well as data obtained in patients that contribute to a better understanding of the impact of nutrients interacting with the gut microbiota on metabolic and behavioural alterations linked to obesity. The gut microbiota composition and function are altered in several pathological conditions including obesity and related diseases i.e. non-alcoholic fatty liver diseases (NAFLD). The gut-liver axis is clearly influenced by alterations of the gut barrier that drives inflammation. In addition, recent papers propose that specific metabolites issued from the metabolic cooperation between the gut microbes and host enzymes, modulate inflammation and gene expression in the liver. This review illustrates how dietary intervention with prebiotics or probiotics influences host energy metabolism and inflammation. Indeed, intervention studies are currently underway in obese and NAFLD patients to unravel the relevance of the changes in gut microbiota composition in the management of metabolic and behavioural disorders by nutrients interacting with the gut microbiota. In conclusion, diet is among the main triggers of NAFLD and the gut microbiota is modified accordingly, underlining the importance of the concomitant study of the nutrients and microbial impact on liver health and metabolism, in order to propose innovative, clinically relevant, therapeutic approaches.

Entities:  

Keywords:  ALT alanine aminotransferase; AST aspartate aminotransferase; AhR aryl hydrocarbon receptor; BA bile acid; FXR farnesoid X receptor; GLP glucagon-like peptide; GPR G protein-coupled receptors; ITF inulin-type fructans; LPS lipopolysaccharides; NAFLD non-alcoholic fatty liver disease; NASH non-alcoholic steatohepatitis; Gut microbiota; Inflammation; Non-alcoholic fatty liver disease; Prebiotics

Mesh:

Substances:

Year:  2019        PMID: 30628563     DOI: 10.1017/S0029665118002756

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  21 in total

Review 1.  Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology.

Authors:  Silvia Sookoian; Carlos J Pirola; Luca Valenti; Nicholas O Davidson
Journal:  Hepatology       Date:  2020-07       Impact factor: 17.425

2.  Prebiotic Effect of Berberine and Curcumin Is Associated with the Improvement of Obesity in Mice.

Authors:  Audrey M Neyrinck; Cándido Robles Sánchez; Julie Rodriguez; Patrice D Cani; Laure B Bindels; Nathalie M Delzenne
Journal:  Nutrients       Date:  2021-04-24       Impact factor: 5.717

3.  Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Eleonora Scorletti; Paul R Afolabi; Elizabeth A Miles; Debbie E Smith; Amal Almehmadi; Albandri Alshathry; Caroline E Childs; Stefania Del Fabbro; Josh Bilson; Helen E Moyses; Geraldine F Clough; Jaswinder K Sethi; Janisha Patel; Mark Wright; David J Breen; Charles Peebles; Angela Darekar; Richard Aspinall; Andrew J Fowell; Joanna K Dowman; Valerio Nobili; Giovanni Targher; Nathalie M Delzenne; Laure B Bindels; Philip C Calder; Christopher D Byrne
Journal:  Gastroenterology       Date:  2020-01-25       Impact factor: 33.883

Review 4.  Diverse roles of microbial indole compounds in eukaryotic systems.

Authors:  Prasun Kumar; Jin-Hyung Lee; Jintae Lee
Journal:  Biol Rev Camb Philos Soc       Date:  2021-06-17

5.  Chitin-glucan and pomegranate polyphenols improve endothelial dysfunction.

Authors:  Audrey M Neyrinck; Emilie Catry; Bernard Taminiau; Patrice D Cani; Laure B Bindels; Georges Daube; Chantal Dessy; Nathalie M Delzenne
Journal:  Sci Rep       Date:  2019-10-02       Impact factor: 4.379

6.  Development of a Repertoire and a Food Frequency Questionnaire for Estimating Dietary Fiber Intake Considering Prebiotics: Input from the FiberTAG Project.

Authors:  Audrey M Neyrinck; Julie-Anne Nazare; Julie Rodriguez; Romain Jottard; Sarah Dib; Monique Sothier; Laurie Van Den Berghe; Maud Alligier; Hélène Alexiou; Véronique Maquet; Sophie Vinoy; Stephan C Bischoff; Jens Walter; Martine Laville; Nathalie M Delzenne
Journal:  Nutrients       Date:  2020-09-15       Impact factor: 5.717

7.  PPAR δ inhibition protects against palmitic acid-LPS induced lipidosis and injury in cultured hepatocyte L02 cell.

Authors:  Yi Li; Chenwei Wang; Jiyuan Lu; Ke Huang; Yu Han; Junlin Chen; Yan Yang; Bin Liu
Journal:  Int J Med Sci       Date:  2019-10-21       Impact factor: 3.642

Review 8.  The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage.

Authors:  Julio Plaza-Díaz; Patricio Solís-Urra; Fernando Rodríguez-Rodríguez; Jorge Olivares-Arancibia; Miguel Navarro-Oliveros; Francisco Abadía-Molina; Ana I Álvarez-Mercado
Journal:  Int J Mol Sci       Date:  2020-11-07       Impact factor: 5.923

9.  Bifidobacterium animalis ssp. Lactis 420 Mitigates Autoimmune Hepatitis Through Regulating Intestinal Barrier and Liver Immune Cells.

Authors:  Hongxia Zhang; Man Liu; Xin Liu; Weilong Zhong; Yanni Li; Ying Ran; Liping Guo; Xu Chen; Jingwen Zhao; Bangmao Wang; Lu Zhou
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

Review 10.  Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective.

Authors:  Konstantinos Prokopidis; Mavil May Cervo; Anoohya Gandham; David Scott
Journal:  Nutrients       Date:  2020-07-30       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.